• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 2

Episode 2 - Immunotherapy in CRPC

Video

During this segment, David Crawford, MD, discusses immunotherapy’s role in castration-resistant prostate cancer (CRPC), and explains how the US Food and Drug Administration’s approval of sipuleucel-T has led to a paradigm shift in the way that CRPC is treated.

Dr Crawford explains the unique capabilities of immunotherapy for advanced disease when compared to conventional treatment options such as cytotoxic chemotherapy.

Additionally, David Quinn, MD, discusses hormonal therapy agents, the key clinical trials that have tested these treatment options, and explains how the trials have demonstrated improved outcomes in CRPC.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Dr Eric Yang
Adam Brufsky, MD, PhD, University of Pittsburgh
Dr Marco Del Riccio
Dr Steven Manobianco
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Related Content
NYC’s largest nursing strike hits Day 5 as nurses push for safer staffing, fair benefits, and workplace protections. Hospitals continue negotiations. | Image credit: @Sansert_AdobeStock.jpeg

NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes

January 16th 2026
Article

New York City nurses continue their strike over staffing, safety, and benefits through negotiations on day 5 of the city’s largest nursing strike.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Center on Health Equity and Access

Health Equity & Access Weekly Roundup: January 16, 2026

January 16th 2026
Article

In this week’s health equity news, ICHRAs may offer flexible health coverage options amid ACA subsidy uncertainties, and advocates rally for mental health funding stability.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

As ACA subsidy extensions face uncertainty, ICHRAs are gaining attention. Here’s what employers and employees should know. | Image credit: @dragonstock_AdobeStock.jpeg

5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall

January 16th 2026
Article

With ACA subsidies in limbo, ICHRAs may reshape how Americans access coverage. Here are 5 FAQs explaining what they are, who benefits, and key trade-offs.

Read More

President Trump’s proposed Great Healthcare Plan promises to lower health care costs for Americans if Congress enacts it. | Image credit: Rawf8 - stock.adobe.com

Trump Announces “The Great Healthcare Plan,” Proposing Direct Payments, Price Transparency, Insurance Reform

January 15th 2026
Article

Trump's Great Healthcare Plan aims to lower drug prices, reduce insurance premiums, and enhance transparency, according to the White House.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.